Childs, a professor of food marketing at Saint Joseph ‘s University in Philadelphia, anxious to witness the response from not only consumers, but also the food industry. Is at a time when analysts speculate sharp rise in food prices, the industry says Childs challenge be, keep food affordable and nutritionally relevant. ‘The new policy space for a win-win with a healthier portion sizes for consumers,’she says. Source: St.
Bayer HealthCare and Onyx Pharmaceuticals today announced that Bayer HealthCare has a New Drug Application submitted to the U.S. Food and Drug Administration Multi for oral kinase inhibitor for the treatment of metastatic regorafenib and / or unresectable gastrointestinal stromal tumors in patients whose disease has progressed despite prior treatment.Continue Reading